FORTIS
Fortis Healthcare Limited (FORTIS) Stock Analysis
Fortis Healthcare Limited is a leading Indian hospital chain operating multi-specialty facilities across the country. It provides inpatient, outpatient, and diagnostic healthcare services. The company serves patients through owned and managed hospitals. It is listed on Indian stock exchanges.
Healthcare › Medical Care Facilities
₹736.50
-6.33% 1W | -31.20% 52W
Market Cap
55.6k CR
P/E Ratio
53.1
52W High
₹1104.3
52W Low
₹734.1
Div. Yield
0.13%
Beta
0.6
50 DMA
₹869.6
200 DMA
₹902
Profit Margin
11%
Inst. Own.
51.5%
📊 CONSOLIDATION
⚠️ BREAKDOWN
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,657 | 1,770 | 1,680 | 1,786 | 1,859 | 1,988 | 1,928 | 2,007 | 2,167 | 2,331 | 2,265 | 2,365 | 2,545 |
| Expenses | 1,386 | 1,440 | 1,396 | 1,405 | 1,516 | 1,554 | 1,553 | 1,572 | 1,676 | 1,775 | 1,759 | 1,832 | 2,008 |
| Operating Profit | 272 | 330 | 284 | 381 | 343 | 435 | 375 | 435 | 491 | 556 | 506 | 532 | 537 |
| OPM % | 16% | 19% | 17% | 21% | 18% | 22% | 19% | 22% | 23% | 24% | 22% | 23% | 21% |
| Other Income | 10 | 18 | 19 | 17 | 14 | -42 | 47 | -29 | 31 | 50 | -34 | -2 | 28 |
| Interest | 31 | 32 | 33 | 35 | 35 | 36 | 45 | 68 | 70 | 75 | 86 | 84 | 80 |
| Depreciation | 79 | 84 | 87 | 92 | 91 | 95 | 97 | 102 | 101 | 106 | 120 | 122 | 122 |
| Profit before tax | 171 | 233 | 183 | 271 | 230 | 261 | 279 | 237 | 351 | 425 | 266 | 324 | 363 |
| Tax % | 27% | 21% | 27% | 25% | 24% | 26% | 9% | 21% | 24% | 23% | 26% | 16% | 25% |
| Net Profit | 124 | 184 | 134 | 203 | 174 | 193 | 254 | 188 | 267 | 329 | 197 | 271 | 273 |
| EPS in Rs | 1.48 | 2.30 | 1.78 | 2.37 | 2.20 | 2.34 | 3.28 | 2.44 | 3.45 | 4.26 | 2.57 | 3.52 | 3.53 |
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,966 | 4,199 | 4,574 | 4,561 | 4,469 | 4,632 | 4,030 | 5,718 | 6,298 | 6,893 | 7,783 | 9,128 | 9,506 |
| Expenses | 3,857 | 4,106 | 4,220 | 4,287 | 4,238 | 4,022 | 3,626 | 4,649 | 5,196 | 5,625 | 6,195 | 7,043 | 7,375 |
| Operating Profit | 109 | 92 | 354 | 274 | 231 | 610 | 404 | 1,069 | 1,101 | 1,268 | 1,588 | 2,085 | 2,131 |
| OPM % | 2.8% | 2.2% | 8% | 6% | 5% | 13% | 10% | 19% | 17% | 18% | 20% | 23% | 22% |
| Other Income | 92 | 299 | 649 | -689 | 228 | 126 | 95 | 367 | 157 | 64 | -11 | 45 | 42 |
| Interest | 152 | 133 | 229 | 258 | 337 | 205 | 166 | 147 | 129 | 131 | 184 | 314 | 325 |
| Depreciation | 235 | 225 | 222 | 239 | 233 | 292 | 291 | 301 | 316 | 342 | 386 | 449 | 470 |
| Profit before tax | -185 | 34 | 552 | -912 | -110 | 239 | 43 | 988 | 814 | 858 | 1,007 | 1,366 | 1,378 |
| Tax % | 2% | -24% | 13% | 2% | 103% | 62% | 230% | 20% | 22% | 25% | 20% | 22% | |
| Net Profit | -130 | 42 | 479 | -934 | -224 | 91 | -56 | 790 | 633 | 645 | 809 | 1,064 | 1,070 |
| EPS in Rs | -3.10 | 0.40 | 8.14 | -19.46 | -3.96 | 0.77 | -1.45 | 7.35 | 7.80 | 7.93 | 10.26 | 13.80 | 13.88 |
| Dividend Payout % | -1% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 13% | 13% | 10% | 7% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 13.0% | 18.0% | 8.0% |
| Profit CAGR | 27.0% | 64.0% | 60.0% |
Shareholding Pattern
Promoters31.17%
FIIs27.18%
DIIs29.79%
Public11.87%
Promoters31.17%
FIIs27.90%
DIIs29.14%
Public11.79%
Promoters31.17%
FIIs27.84%
DIIs29.33%
Public11.65%
Promoters31.17%
FIIs25.98%
DIIs31.35%
Public11.50%
Promoters31.17%
FIIs25.20%
DIIs32.23%
Public11.40%
Promoters31.17%
FIIs31.22%
DIIs20.69%
Public16.92%
Promoters31.17%
FIIs23.24%
DIIs31.14%
Public14.44%
Promoters31.17%
FIIs27.40%
DIIs29.46%
Public11.98%
Promoters31.17%
FIIs25.98%
DIIs31.35%
Public11.50%
Promoters31.17%
FIIs25.20%
DIIs32.23%
Public11.40%
FORTIS
Holdings Analysis
Key strengths & risk signals
61
Overall
75
Fundamental
47
Technical
Risks (4)
NEGLIGIBLE DIVIDEND! 0.13% yield - little to no income.
POOR YEAR! Stock declined 31.2% in the last year.
WEAK POSITION! Current price (736.5) is below both moving averages.
WEAK! Trading at 0.6% of 52W range - near yearly lows.
Strengths (4)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
OVERSOLD! RSI at 26.9 - potential bounce opportunity.
LOW VOLATILITY! Beta of 0.60 - stable stock, less market risk.
BULLISH SENTIMENT! In last 30 days: 10 up days, 20 down days. Avg volume on up days: 1,890,275 vs down days: 1,734,516. Ratio: 1.09x
Fundamental & Technical Analysis
61Overall
75Fundamental
47Technical
Fundamental Breakdown
Growth Quality
26/30
Revenue CAGR: 13.3% (GOOD, 11/15). Profit CAGR: 21.0% (EXCELLENT, 15/15).
Profit Margin
5/10
DECENT EFFICIENCY! 11.0% profit margin - acceptable profitability.
PEG Valuation
5/10
OVERVALUED! PEG of 2.53 means expensive relative to growth rate.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.13% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
16/20
LESS PUBLIC HOLDING! 16.65% public ownership - good institutional/promoter control.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
3/10
BEARISH TREND! 50-day average (869.6) is below 200-day average (902.0) - negative signal.
Price Position
2/10
WEAK POSITION! Current price (736.5) is below both moving averages.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
0/10
POOR YEAR! Stock declined 31.2% in the last year.
Volume Sentiment
20/30
BULLISH SENTIMENT! In last 30 days: 10 up days, 20 down days. Avg volume on up days: 1,890,275 vs down days: 1,734,516. Ratio: 1.09x
RSI
5/5
OVERSOLD! RSI at 26.9 - potential bounce opportunity.
52W Range
1/5
WEAK! Trading at 0.6% of 52W range - near yearly lows.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 6.3% (1 week), 15.4% (1 month), 22.7% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.60 - stable stock, less market risk.
FORTIS
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q1FY272026-09-10 | Concall PDF | |
| Q4FY262026-05-29 | Concall PDF | |
| Q3FY262026-02-20 | Concall PDF | |
| Q2FY262025-11-17 | Concall PDF |
Peer Comparison
Healthcare · Medical Care Facilities · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FORTIS | ₹736.50 | 53.1 | 11.0% | 13.3% | 21.0% | -31.2% | 61 | BREAKDOWN | +2.3% | +0.2% | +17.5% | +7.6% |
| ASTERDM | ₹674.40 | 109.3 | 6.5% | 15.7% | -3.0% | -2.8% | 56 | BREAKDOWN | -81.2% | -88.5% | +21.6% | +10.9% |
| NH | ₹1,719.40 | 42.5 | 9.0% | 20.5% | 9.9% | -3.8% | 59 | APPROACHING SUPPORT | +5.3% | -7.5% | +78.0% | +3.5% |
| MEDANTA | ₹1,240.00 | 60 | 11.9% | 17.2% | 19.5% | -6.7% | 64 | BREAKDOWN | -0.2% | +10.2% | +26.5% | +12.5% |
| MAXHEALTH | ₹846.00 | 56.7 | 16.7% | 22.4% | 9.3% | -28.7% | 55 | BREAKDOWN | +4.9% | -5.6% | +16.7% | +10.4% |
| KIMS | ₹685.60 | 134.4 | 4.8% | 21.3% | -10.5% | -4.3% | 58 | BREAKDOWN | -47.2% | -2.4% | +35.3% | +9.8% |
| APOLLOHOSP | ₹7,890.00 | 54.3 | 7.9% | 14.8% | 33.3% | -0.2% | 63 | BREAKDOWN | +34.2% | +9.7% | +20.6% | +6.6% |
| RAINBOW | ₹1,248.90 | 44.4 | 15.7% | 13.1% | 9.7% | -7.6% | 64 | BOUNCE FROM SUPPORT | +13.3% | -21.3% | +33.2% | +2.2% |
Data from TradeAlone · Updated daily
FORTIS News
Fortis Healthcare Limited Acquires Suguna Hospital in Bengaluru for INR 277 Crores2026-10-28Fortis Healthcare Limited (fortis) Signs Agreements to Provide Healthcare Services to New Super Specialty Hospital in Delhi2026-09-16Fortis Healthcare Limited (NSE: FORTIS) breaks below support, falls 5% intraday2026-08-12Fortis Healthcare Limited (FORTIS) gains 5% intraday, nears resistance2026-08-07Fortis Healthcare Limited (fortis) Q1 FY27: Revenue Up 17.5%, Operating Ebitda Margin at 22.3%2026-08-06Fortis Healthcare Limited Appoints Vijender Singh as Managing Director & CEO of Agilus Diagnostics2026-07-20Fortis Healthcare Limited (fortis) Expands Presence in Odisha with New 300-bed Hospital2026-07-03Fortis Healthcare Limited (fortis) Q4 FY26: Revenue Up 17.8%, PAT Surges 44.2%2026-05-22
